Mounjaro can cause bad breath due to changes in digestion, reduced saliva production, and metabolic shifts such as ketosis
Medically Supervised Care Our platform is a user-friendly and supportive space where individuals receive personalized, medically supervised careall designed to make sustainable weight loss attainable and tailored to the individual
Reductions in caloric intake are found across all body mass index (BMI) categories
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone
(Empagliflozin is one of the active drugs in Synjardy.) Its important to note that animal studies dont always predict what will happen in people